Faculty profile

Philip Wong

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Philip Wong

Researcher

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
44 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (1 CIHR, 1 SSHRC), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Factorial Design Hypofractionation Immunotherapy International Neoadjuvant Perioperative Phase Iii Radiation Therapy

Latest papers

Adaptive Radiation Therapy in the 0-7-21 Regimen: A Retrospective Study of Tumor Volumetric Response.
Advances in radiation oncology · 2026 · senior author
Phase 1/2 Trial of Durvalumab Plus Tremelimumab and Stereotactic Body Radiation Therapy for Metastatic Head and Neck Carcinoma.
International journal of radiation oncology, biology, physics · 2026 · senior author
Impact of a Multidisciplinary Palliative Radiation Therapy Clinic on Patient Care.
Advances in radiation oncology · 2026

All 60 publications

Latest funding

Lattice Radiation Therapy versus Conventional Radiation Therapy for the Palliation of Large Tumors (LATTICE-PAL)
CIHR · 2026 · Co-investigator
$960,076
Hypofractionated Alternative Radiation with MOdulation of Neoadjuvant/perioperative immunotherapY in Sarcoma (HARMONY)
CIHR · 2025 · Nominated PI
$1,407,600
Accelerating a Culture Shift and Behaviour Change: Co-developing a Patient Engagement in Research Toolkit
CIHR · 2024 · Co-investigator
$25,000

All 4 grants and awards

60 publications.

Adaptive Radiation Therapy in the 0-7-21 Regimen: A Retrospective Study of Tumor Volumetric Response.

Chelvarajah RC, Bartolucci DD, Javor J, Taylor E, Liu ZA, Ye XY, Serban M, Cummings B, Dawson L, Keilty D, Hahn E, Tsai CJ, Wong P

Advances in radiation oncology2026Senior author

DOI: 10.1016/j.adro.2026.102088 PMID: 42382438

Phase 1/2 Trial of Durvalumab Plus Tremelimumab and Stereotactic Body Radiation Therapy for Metastatic Head and Neck Carcinoma.

Bahig H, Ye RZ, Aubin F, Nguyen-Tan PF, Soulieres D, Debenham BJ, Charpentier D, Palma DA, Chua N, Winquist E, Jamal R, Sultanem K, Ballivy O, Filion E, Mathew J, Maganti M, Wong P

International journal of radiation oncology, biology, physics2026Senior author

DOI: 10.1016/j.ijrobp.2026.07.052 PMID: 42586218

Impact of a Multidisciplinary Palliative Radiation Therapy Clinic on Patient Care.

Agrawal A, Javor J, Delposo-Lee K, Wong P, Taylor E, Dawson LA, Wong R, Millar BA, Chelvarajah R, Wattakiyanon N, Bezjak A, Cummings B, Tsai CJ

Advances in radiation oncology2026

DOI: 10.1016/j.adro.2026.102065 PMID: 42294412

Simulation-Free Single-Fraction High-Dose Radiotherapy for Non-Spine Bone and Soft Tissue Metastases.

Javor J, Mesci A, Wong P, Cummings BJ, Safavi A, Dawson LA, Wong RK, Delposo-Lee K, Chelvarajah R, Agrawal A, Wattakiyanon N, Rosewall T, Tadic T, Taylor E, Tsai CJ

Practical radiation oncology2026

DOI: 10.1016/j.prro.2026.06.009 PMID: 42413576

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.

Icht O, Sun A, Wong P, McPartlin A, Muniz TP, Spreafico A, Saibil SD, Lukens JN, Karam SD, De Almeida J, Butler MO, Tsai CJ

Frontiers in oncology2026

DOI: 10.3389/fonc.2026.1841070 PMID: 42518820

Long-term real-world outcomes following preoperative radiotherapy and conservative surgery for trunk and extremity soft tissue sarcomas: a retrospective cohort study.

Krcek R, Wattakiyanon N, Griffin AM, Liu ZA, Catton CN, Roohani S, Shultz DB, Wong P, Kirsch DG, Othman HM, Ferguson PC, Tsoi K, Wunder JS, Chung PWM

EClinicalMedicine2026

DOI: 10.1016/j.eclinm.2026.104046 PMID: 42433274

Artificial intelligence (AI) for early identification of radiotherapy related toxicities from the electronic health records of patients with head and neck cancer.

Liu A, Alfadli F, Mathew JM, Parmelee S, Waldron J, Kwan JYY, Aviv S, Nguyen MM, Mokriak V, Pettengell C, Wong P

Clinical and translational radiation oncology2026Senior author

DOI: 10.1016/j.ctro.2026.101165 PMID: 42005711

Evaluating the environmental Effects of Simulation-Free radiation therapy for palliative treatments.

Lee J, Javor J, Tsai CJ, Cummings B, Mesci A, Kong V, Millar BA, Dawson LA, Wong R, Delposo-Lee K, Taylor E, Wong P

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026Senior author

DOI: 10.1016/j.radonc.2026.111472 PMID: 41812863

Integrity of delivered dose in temporally fractionated lattice radiotherapy amid anatomical changes and setup uncertainties.

Liu N, Parent A, Tsang Y, Heng VJ, Wong P, Kirsch DG, Mesci A, Malik N, Chung P, Keilty D, Hahn E, Hodgson D, Tsai J, Dawson LA, Lukovic J, Serban M

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111457 PMID: 41765185

Efficacy and safety of metastasis-directed therapy for oligometastatic cancer: a systematic review and meta-analysis of randomized controlled trials.

Chen D, Khoshkish E, Jomy J, Arnold K, Yi J, Palma D, Liu M, Ye XY, Liu Z, Boldt G, Wong P, Raman S

Radiation oncology (London, England)2026

DOI: 10.1186/s13014-026-02853-6 PMID: 42192575

Something wrong or missing on this profile? Suggest a correction

Philip Wong

Research

Latest papers

Latest funding

Adaptive Radiation Therapy in the 0-7-21 Regimen: A Retrospective Study of Tumor Volumetric Response.

Phase 1/2 Trial of Durvalumab Plus Tremelimumab and Stereotactic Body Radiation Therapy for Metastatic Head and Neck Carcinoma.

Impact of a Multidisciplinary Palliative Radiation Therapy Clinic on Patient Care.

Simulation-Free Single-Fraction High-Dose Radiotherapy for Non-Spine Bone and Soft Tissue Metastases.

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) -&#xa0;a single arm, phase 2 clinical trial.

Long-term real-world outcomes following preoperative radiotherapy and conservative surgery for trunk and extremity soft tissue sarcomas: a retrospective cohort study.

Artificial intelligence (AI) for early identification of radiotherapy related toxicities from the electronic health records of patients with head and neck cancer.

Evaluating the environmental Effects of Simulation-Free radiation therapy for palliative treatments.

Integrity of delivered dose in temporally fractionated lattice radiotherapy amid anatomical changes and setup uncertainties.

Efficacy and safety of metastasis-directed therapy for oligometastatic cancer: a systematic review and meta-analysis of randomized controlled trials.

Lattice Radiation Therapy versus Conventional Radiation Therapy for the Palliation of Large Tumors (LATTICE-PAL)

Hypofractionated Alternative Radiation with MOdulation of Neoadjuvant/perioperative immunotherapY in Sarcoma (HARMONY)

Accelerating a Culture Shift and Behaviour Change: Co-developing a Patient Engagement in Research Toolkit

Lab-on-chip testing ex vivo tumors treated with non-thermal plasma

Frequent collaborators

Andrew Hope

Fei-Fei Liu

David Roberge

Kim Tsoi

Rebecca Gladdy

Monica Serban

Jelena Lukovic

Anna Spreafico

Thomas Gervais

Carol Swallow

David Kirsch

Laura Dawson

Michael Yan

Francis Rodier

Houda Bahig

Michael Milosevic

Ervin Sejdic

Marc Gaudet

Robert Smith

Erin Kelly

Sareh Keshavarzi

Erin Kelly

John de Almeida

Dongsheng Tu

Elliot Wakeam

Rongmin Zhao

Lisa Barrett

David Goldstein

Scott Bratman

Keith Tsoi

Bertrand Routy

Quynh Pham

Eric Vigneault

Eric Winquist

Breffni Hannon

David Hodgson

Alnoor Ramji

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.